Leveraged & Inverse Content Hub Tailwinds Are Blowing Behind Healthcare and the “CURE” ETF By Ben HernandezSeptember 3, 2021
The Responsible Investing Content Hub Climate Change Is a Public Health Issue By Max ChenSeptember 1, 2021
Thematic Investing Content Hub Check Out AGNG as Healthcare Systems Adapt to an Aging Population By Ben HernandezAugust 25, 2021
Innovative ETFs Content Hub Moderna Vaccine Is Granted Authorization in Australia By Max ChenAugust 9, 2021
Leveraged & Inverse Content Hub Extra Bullish on Healthcare? Consider Leverage, the CURE ETF By Ben HernandezAugust 2, 2021
Innovative ETFs Content Hub A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark By Max ChenJune 30, 2021
Innovative ETFs Content Hub The Biotech Trek: A Short History from 1993 to 2021 By Max ChenJune 29, 2021
Innovative ETFs Content Hub Healthcare Services ETFs Could Continue to Rally By Max ChenJune 24, 2021
Innovative ETFs Content Hub Spice Up Your Healthcare Exposure with Some Momentum By Ben HernandezJune 22, 2021
Modern Alpha Content Hub The BioRevolution: An ETF That Taps Into Nearly Everything By Max ChenJune 21, 2021
Thematic Investing Content Hub How to Invest in a Breakout Healthcare Industry in China By Ben HernandezJune 10, 2021
Innovative ETFs Content Hub Greater Regulatory Scrutiny Could Weigh on Biotech ETFs By Max ChenMarch 24, 2021
